Publications

Fan X, Liu E, Freudenreich O, Park JH, Liu D, Wang J, Yi Z, Goff DC, Henderson DC. 

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 118, 211-217.

Liu D, Fan X, Wang Y, Yang Z, Zhuo K, Song Z, Wu Y, Li C, Wang J, Xu Y.  

Deficient inhibition of return in chronic but not first-episode patients with schizophrenia.  Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2010; 34, 961-967.

Wang J, Liu E, Freudenreich O, Goff DC, Henderson DC, Fan X. 

Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 124, 49-53.

Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff DC, Henderson DC. 

Rosiglitazone and cognitive function in clozapine treated patients with schizophrenia: a pilot study.  Psychiatry Research, 2012; 200, 79-82.

Wang J, Fan X, Liu D, Yi Z, Freudenreich O, Goff DC, Henderson DC. 

Physical activity, food intake and metabolic abnormalities in patients with schizophrenia.  Schizophrenia Research, 2012; 140, 260-261.

Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP. 

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.  Psychopharmacology (Berl), 2013; 225, 627-635.

Fan X, Song X. 

Non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics.  Evidence based Mental Health, 2013; 16, 10.

Zhuo K, Lu Y, Yang Z, Fan X, Song Z, Liao L, Ji C, Zhu D, Yu S, Yan C, Chan RCK, Goff DC, Xu Y, Liu D. 

Prospective memory performance in patients with drug-naïve, first-episode psychosis.  Schizophrenia Research, 2013; 143, 285-290.

Li J, Li X, Liu E, Song X, Copeland P, Freudenreich O, Goff DC, Henderson DC, Fan X. 

No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.  Schizophrenia Research, 2013; 146, 40-45.

Song X, Fan X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. 

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight.  Schizophrenia Research, 2013; 150, 269-73.

Guo X, Li J, Wei Q, Fan X, Kennedy DN, Shen Y, Chen H, Zhao J. 

Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.  PLoS One, 2013; 8, e83679.

Song X, Li X, Gao J, Ding M, Zhao J, Li Y, Fan X, Lv L. 

APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.  PLoS One, 2014; 9, e93902.

Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Ziedonis D, Fan X, Lv L. 

Activation of Th17 cells in drug naïve, first episode schizophrenia.  Prog Neuropsychopharmacol Biol Psychiatry, 2014; 51, 78-82.

Guo X, Li J, Wang J, Fan X, Hu M, Shen Y, Chen H, Zhao J. 

Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naïve, first-episode patients with schizophrenia.  Schizophrenia Research, 2014; 152, 339-343.

Song X, Fan X, Li X, Zhang W, Gao J, Zhao J, Harrington A, Ziedonis D, Lv L. 

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first episode schizophrenia.  Psychopharmacology (Berlin), 2014; 231, 319-325.

Song X, Fan X, Zhang J, Zheng H, Li X, Pang L, Chen X, Zhang W, Ziedonis D, Lv L. 

The relationship between serum levels of prolactin and the inflammatory status in drug naïve, first episode schizophrenia.  The World Journal of Biological Psychiatry, in press.

Sheng J, Chiang C, Li C, Wang J, Harrington A, Yi Z, Liu D, Fan X.   

Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia.  Psychiatry Research, in press.

Guo W,  Hu M, Fan X, Liu F, W R, Chen J, Guo X, Xiao C, Quan M, Chen H, Zhai J, Zhao J. 

Decreased gray matter volume in the left middle temporal gyrus as a candidate endophenotype for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings.  Schizophrenia Research, in press.

Song X, Fan X, Li X, Kennedy D, Hao Y, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L.

Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.  Schizophrenia Research, in press.

Song X, Pang L, Feng Y, Fan X, Li X, Zhang W, Gao J, Zhang J, Nemani K, Zhang H, Lv L. 

Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.  J of Neuroscience, in press.

Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X.

Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF.  Journal of Psychiatric Research, in press.

Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy D, Harrington A, Ziedonis D, Fan X, Zhao M.

Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioral Brain Research, in press.